dr. camidge on biomarker combinations in nsclc
Published 6 years ago • 146 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:52
dr. camidge on optimal therapy in egfr nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
1:00
dr. camidge on phase i study with azd9291 in nsclc
-
1:11
dr. clarke on the state of biomarkers in nsclc
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
2:56
dr bazhenova on improving biomarker development in lung cancer
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:58
dr. camidge on mechanisms of resistance to tkis in nsclc
-
1:27
dr. camidge on the keynote-024 trial in nsclc
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
1:37
dr. camidge on the alex trial in patients with alk nsclc
-
1:51
dr. camidge discusses treatment of patients with alk nsclc
-
1:51
dr. papadimitrakopoulou on biomarker-driven clinical trials in nsclc
-
1:28
dr. camidge on met as a target in lung cancer
-
0:30
copy of dr. camidge on the keynote-024 trial in nsclc
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
1:28
dr. kim on the importance of biomarker testing for lung cancer